Abstract
Introduction
In the past few years it became evident from transcription studies (tiling array and tag sequencing data) that the eukaryotic genome is transcribed to a much higher extent than assumed. In addition to this process of pervasive transcription which produces a high amount of non-coding RNAs with unknown functions [1] [2] [3] , the presence and function of rare messages or lower abundance transcripts is intensively discussed. They are widely present in yeast, fly, mouse, rat, human, Arabidopsis and rice and account for 20%-40% of the mRNA mass [4] . So far, little is known about their specific regulation and function [5, 6] . It has been suggested that high-abundance transcripts are produced by housekeeping genes, while low-abundance transcripts may meet more specialized functions [5] . Here we analysed the transcript profile of the human acyl-CoA binding protein (ACBP) gene locus with particular emphasis on the regulation of low-abundance transcripts. We selected this gene because ACBP functions as a typical housekeeping protein with basic cellular functions such as fatty acid metabolism and steroidogenesis but is also described to mediate highly specialized and regulated processes such as insulin secretion [7, 8] , cholecystokinin secretion [9] , inflammation [10] [11] [12] or apoptosis [13] . ACBP [14, 15] . It also interacts with peripheral benzodiazepine receptors that have been found at high levels in steroidogenic organs, lymphocytes, macrophages/granulocytes, platelets and in the peripheral nervous system [15] [16] [17] [18] [19] . The question arises how ACBP can achieve multiple regulatory functions. So far, three different splice variants of the ACBP gene have been reported [20] . By using bioinformatic approaches such as expressed sequence tag database screening and ab initio gene prediction followed by experimental verifications we identified 10 
and its cleavage peptides also play an important role in ␥-aminobutyric acid A receptor activity regulation. Based on this function it is called diazepam binding inhibitor or Endozepine

Materials and methods
In silico analyses of the human Acbp gene locus
Acbp transcript variants were identified by screening the EST database (dbEST) of NCBI in combination with ab initio gene prediction using the GenScan gene structure recognition program [21] . Genomic Acbp sequence was obtained from GenBank (NT_022135. 15 Table 1 . Amplification was carried out as described previously [20] . The sequence of each amplified DNA fragment from all tissues tested was purified using the QIAquick Gel Extraction Kit (Qiagen) and sequenced as described by Nitz et al. [20] . Sequence data were analysed by Lasergene sequence analysis software (DNASTAR). 
Nomenclature of Acbp transcript variants
Based on this, we entitled the four known Acbp transcript variants as 1A(1) (NM_001079862), 1B (M14200), 1D(1)-B(1) (NM_020548) and 1C (NM_001079863) encoding the three known isoforms ACBP-1A (87 amino acids (aa), NP_001073331), ACBP-1B (104 aa, NP_065438) and ACBP-1C (88 aa, NP_001073332). Although NM_020548 is deposited in GenBank (NCBI) as reference sequence that includes exon 1D(1) as first exon preceding exon 1B, 1D(1) is not included in the current
5Ј-rapid amplification of cDNA ends (RACE)
Quantification of Acbp transcript variants
ng of human SREBP-1A, -1C, -2, HNF-1␣, HNF-4␣, NF-B-p50 or NF-B-p65 expression plasmids. In control approaches the empty vector pcDest40 was co-transfected with the promoter constructs. Stimulation experiments (control: without stimulation) was performed after cells reached confluence. The luciferase reporter vector pGL3 (was included in all transfection experiments for normalization using the Bright-Glo luciferase assay system (Promega).
Chemiluminescence measurements were done as described previously [20] . Relative 
Table 1 Primers used for RT-PCR and RACE-PCR
Nucleotides of the first exon are in italics, nucleotides of the corresponding following exon in normal. F ϭ forward; R ϭ reverse.
1A (1) 
Results
Identification of ACBP splice variants by dbEST screening
1). In ACBP-1G, exon 1G replaces exon 1A(1) and accounts for the alternative N-terminus of 64 aa. Transcripts 1A(2)-B(1) and 1A(2)-B(2) encode for the known isoform ACBP-1B.
Verification of alternative Acbp splice variants by RT-PCR
Multiple alternative Acbp transcript variants were discovered by means of dbEST screenings and a computational gene-finding approach described above. To verify the screening results and the predicted exon positions in the genomic Acbp locus RT-PCR was performed on poly(A)
ϩ RNA from human adipose tissue, liver, (Fig. 4) (Fig. 5B ). For this purpose we selected those novel transcript variants which encode for putative ACBP isoforms (Fig. 1and 4A) . In all five tissues, the novel transcript variants were expressed at extremely lower levels compared to 1A (1) 
hippocampus, heart and skeletal muscle followed by sequencing of RT-PCR products. We obtained 13 PCR products of appropriate sizes corresponding to 13 different alternative transcript variants (Fig. 4A). Using the forward primer 1A(1)-G an additional non-EST based transcript variant of 415 bp could be amplified containing exon D(4) instead of exon G, spliced between exons 1A(1) and B(2). This randomly detected transcript was entitled 1A(1)-D(4).
Mapping of transcription start sites
)-B(2) which holds 5 bp less at the 5Ј-part of exon B(1) (Figs 1 and 2). We could not identify a distinct TSS for exon 1B, indicating that this exon is rather an internal than a separate alternative first exon. In case of the previously unknown alternative first exon 1D we used two different primers, one accordingly to the exon boundary 1D(1) and one complementary to exons 1D(1)-B(1). In both cases, we identified two TSSs separated by 10 bp (Fig. 2) represented by two overlapping RACE products of 231 bp and 220 bp (transcript 1D(1)) and 236 bp and 225 bp (transcript 1D(1)-B(1)) (Fig. 1). For exon 1C we identified three different TSSs (RACE products 298 bp, 253 bp and 250 bp) separated by 44bp (TSS1 and 2) and 2bp (TSS2 and 3). A faint fourth band above 300 bp was not accessible for sequencing. This band possibly represented the 5Ј-end of exon 1C as indicated by ESTs BG036730 and BI829637. To analyse if ab initio exons G and 1G are indeed internal or first exons we used a primer spanning this exon and exon 2. Nested-PCR resulted in three major products of 501 bp, 240 bp and 307 bp where the largest one represented a transcript whose 5Ј-terminus was defined by TSS2 of exon 1D(1) that contained a further 65 bp comprising 3Ј-extension of exon D(2) that was not supported by ESTs or ab initio predictions. In this case, the first exon 1G is a second 3Ј-exon of 1D(1) and was entitled exon 1D(3) (Figs 2 and 3). The 240 bp product represented a transcript including exon 1A as alternative first exon followed by exon G which here is used as an internal exon. We classified this transcript variant as 1A(1)-G. Additionally, by sequencing the product of 307 bp, exon G was also shown to be a distinct alternative first exon with a specific TSS located 194 bp downstream of TSS2 of exon 1D(1) and accordingly, with a distinct promoter. We named this transcript variant 1G (Figs 1 and 2). Some minor bands were obtained which could not be sequenced but maybe could represent further 5Ј-termini.
Tissue-specific distribution of Acbp transcripts
Estimation of the abundance of novel Acbp transcript variants
Real-time PCR was also performed to analyse the abundance of the novel Acbp transcripts in relation to the main transcript 1A(1)
that showed very high expression levels. Of the transcripts encoding isoform ACBP-1B, A(1)-B(1) showed the highest expression levels, followed by a clear decrease of abundance of 1A(1)-B(2), 1D(1)-B(1), 1A(2)-B(1) and 1A(2)-B(2). In liver, adipose tissue and hippocampus a relative abundance of 1A(1)-B(1) of 2.6%, 1.6% and 1.1%, respectively, could be observed, in heart and skeletal muscle of only 0.3% and 0.1%. In general, the non-EST based transcript variants 1A(2), 1A(1)-G, 1G, 1A(2)-B(1) and 1A(2)-B(2) showed the lowest expression levels with very low levels for 1A(2)-B(1) and 1A(2)-B(2) in comparison to 1A(1). As transcripts 1A(1)-G and 1G contain the same 3Ј-exon boundary of exon G, no specific Taqman assay could be designed for 1G (Figs 1 and 2). Accordingly, real-time analyses resulted in a co-detection of these transcripts. Anyhow, the expression levels of 1G were in general clearly higher as those of 1A(1)-G. Our real-time analyses revealed the novel transcript variants as lowabundance transcripts in comparison to 1A(1).
Specific regulation of Acbp transcripts by insulin and glucose
In rats ACBP is reported to be regulated by feeding status [24] 
Basal activity of alternative Acbp promoters
Based on 5Ј-RACE results we produced a series of eight alternative Acbp promoter fragments and cloned them upstream of the SEAP reportergene (Fig. 7A) 1A(1), 1A(1)-B(1), 1A(1)-B(2), 1A(1 (Fig. 8A) (Fig. 7B) . On average, SREBP-1A caused a 5.9-fold and SREBP-1C a 3.1-fold activation of promoter activity. Significant differences in trans-activation levels were obtained using SREBP2 with the high- 
. All fragments include the TSS and are characterized by the same 5Ј-end but differing 3Ј-termini that where related to the corresponding first exon. Promoter fragments were PA1 (324 bp) and PA2 (339 bp), directing the expression of Acbp transcript variants
SREBPs and HNF-4␣ differentially induce the activity of Acbp promoters
ACBP is described to be regulated by SREBPs which are important transcription factors of fatty acid and cholesterol metabolism. To analyse if the alternative Acbp promoters are differentially induced by SREBPs we co-transfected HepG2 cells with Acbp promoter constructs and nSREBP-1A, nSREBP-1C or nSREBP-2. All eight promoters were activated by all SREBPs, but to a different extend
05). (C) Effects of TNF-␣, (D) IL-1␤, (E) IFN-␥ on transcript levels of Acbp-1A(1) and -1G in HepG2 and THP-1 cells. Statistical relevance was verified by two-sided t-test (***
est activation of 43- (1) were not affected. (1) (Fig. 6C) . In THP-1 cells TNF-␣ led to a specific 1G induction of 7.8-fold after 4 hrs (Fig. 7) . In both cell lines, transcript 1G was also significantly activated by 5.4-fold in HepG2 and 10.4-fold in THP-1 cells after 4 hrs exposition to IL-1␤ (Fig. 6D) . Beside LPS, PGN-EB, TNF-␣ and IL-1␤ which are known to induce the NF-B pathway, we used IFN-␥ as stimulus (Fig. 6E) 
In HepG2 cells no effect of LPS and PGN-EB could be observed (data not shown). However, a time-course experiment in HepG2 cells using indicated amounts of TNF-␣ as stimulus revealed a significant increase of transcript 1G up to 16-fold after 6 hrs with no induction of 1A
Stimulatory effects of NF-B, cytokines and bacterial components on promoter PG2
To examine if the alternative promoter PG2 can be transactivated by NF-B transcription factors we transiently transfected HepG2 cells with subunits p50 and p65 and assayed the promoter activity in relation to basal activity. NF-B subunits p50/p65 mediated a 5.6-fold activation of PG2 activity (Fig. 8C) (Fig. 9) 
Discussion
Low-abundance transcripts were traditionally considered as transcriptional 'noise'. Instead, low-abundance transcripts represent the majority of mRNAs in mammals [6, 25] . They are often not conserved between species and are described as genome specific or species specific [26, 27] . Unlike the higher abundance transcripts which fulfil housekeeping functions, lower abundance transcripts meet specialized functions [5] . They are involved in cellular differentiation, metabolism, phenotypic alternation and regulation of gene expression by sequestering nucleic acid binding proteins and in the production of low abundance proteins [26] 
